alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

109TH CONGRESS 

2D SESSION H. R. 4743 

To amend part D of title XVIII of the Social Security Act to require 

prescription drug plans to provide enrollee notice of less expensive part 

D covered drugs that may be substituted for dispensed drugs. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 14, 2006 

Mr. FORD introduced the following bill; which was referred to the Committee 

on Energy and Commerce, and in addition to the Committee on Ways 

and Means, for a period to be subsequently determined by the Speaker, 

in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend part D of title XVIII of the Social Security 

Act to require prescription drug plans to provide enrollee 

notice of less expensive part D covered drugs that may 

be substituted for dispensed drugs. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ENROLLEE NOTICE OF AVAILABILITY OF LESS 

4 EXPENSIVE COVERED PART D DRUG. 

5 (a) IN GENERAL.—Section 1860D–4(a) of the Social 

6 Security Act (42 U.S.C. 1395w–104(a)) is amended by 

7 adding at the end the following new paragraph: 
2 

•HR 4743 IH 

1 ‘‘(5) INFORMATION ON AVAILABILITY OF LESS

2 EXPENSIVE COVERED PART D DRUGS.—If a PDP 

3 sponsor provides an explanation of benefits to an en4 rollee under a prescription drug plan with respect to 

5 a covered part D drug dispensed to the enrollee and 

6 there is another covered part D drug that could have 

7 been substituted for the drug dispensed and that has 

8 a lower level of cost-sharing to the enrollee, the 

9 sponsor shall provide the enrollee, as part of such 

10 explanation of benefits or otherwise, with the infor11 mation on— 

12 ‘‘(A) the name of such drug; 

13 ‘‘(B) the lower level of cost-sharing for 

14 such drug; and 

15 ‘‘(C) the reduction in cost-sharing that 

16 would have resulted from the substitution of 

17 such drug.’’. 

18 (b) EFFECTIVE DATE.—The amendment made by 

19 subsection (a) shall apply with respect to information re20 lating to drugs dispensed on or after the first day of the 

21 first month that begins more than 60 days after the date 

22 of the enactment of this Act. 

Æ
No. 09-9593.

#### Gayot Dorval, Petitioner v. United States.

559 U.S. 1081, 130 S. Ct. 2124,

176 L. Ed. 2d 747,

2010 U.S. LEXIS 3221.

April 19, 2010.

Petition for writ of cer-tiorari to the United States Court of Appeals for the Eleventh Circuit denied.
<PAGE>

Exhibit 32

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Bullion River Gold Corp. (the
"Registrant") on Form 10-QSB for the period ended September 30, 2007, as filed
with the Securities and Exchange Commission on the date hereof (the "Quarterly
Report"), I, Peter M. Kuhn, Chief Executive Officer and Chief Financial Officer
of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1) The Quarterly Report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2) The information contained in the Quarterly Report fairly presents,
in all material respects, the financial condition and result of operations of
the Registrant.


                                        BULLION RIVER GOLD CORP.


Dated:   November 30, 2007              By:  /s/ Peter M. Kuhn
                                             ----------------------------------
                                             Peter M. Kuhn
                                             Chief Executive Officer and
                                             Chief Accounting Officer
No. 09-9280.

#### Rickey Sabedra, Petitioner v. Rick Thaler, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

559 U.S. 1090, 130 S. Ct. 2398,

176 L. Ed. 2d 765,

2010 U.S. LEXIS 3520.

April 26, 2010.

Motion of petitioner for leave to proceed in forma pauperis denied, and petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit dismissed. See Rule 39.8.
1 In The



### Court of Appeals

Ninth District of Texas at Beaumont

_________________

NO. 09

- 18

- 00291

- CV



### _________________

$12,537.00 U.S. CURRENCY (JOSEPH ALLAN EDWARDS) , Appellant

V.

THE STATE OF TEXAS , Appellee

________________________________________________________________________

On Appeal from the 410th District Court

Montgomery County, Texas

Trial Cause No. 16

- 02

- 02059

- CV

________________________________________________________________________

MEMORANDUM OPINION

The trial court signed a final judgment on June 2 6 , 2018. Joseph Allan

Edwards filed a notice of appeal but failed to file a brief. On November 8 , 2018, we

notified the parties that the brief had not been filed and that the appeal would be

submitted without briefs unless we received the brief and motion for extension

within ten days . Our notice warned Edwards that his failure to file a brief could result

in a dismissal of the appeal for want of prosecution . On Novem ber 20 , 2018, we2 notified the parties that the appeal would be submi tted to the Court on December 11,

2018, without briefs and without oral argument. See Tex. R. App. P. 39.8.

In the absence of a brief assigning error for appellate review, we dismiss the

a ppeal for want of prosecution. See Tex. R. App. P. 38.8(a)(1); Tex. R. App. P.

42.3(b).

APPEAL DISMISSED

.

________________________________ STEVE McKEITHEN

Chief Justice

Submitted on December 11, 2018

Opinion Delivered December 20, 2018

Before McKeithen, C.J., Horton and Johnson, JJ.
No. 09-8364.

#### Anthony C. Pryor, Petitioner v. Michael Sheets, Warden.

559 U.S. 994, 130 S. Ct. 1742,

176 L. Ed. 2d 216,

2010 U.S. LEXIS 2284.

March 8, 2010.

Petition for writ of cer-tiorari to the United States Court of Appeals for the Sixth Circuit denied.
Order entered February 4, 2015.

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-14-01019-CV

FEYSAL AYATI-GHAFFARI AND IRANA HAGNAZARI, Appellants

V.

HAZAWIPERI JACKIE GUMBODETE AND JOSE ANAYA, Appellees

On Appeal from the 429th Judicial District Court

Collin County, Texas

Trial Court Cause No. 429-04867-2012

ORDER

Appellants’ January 21, 2015, motion to require appellees to re-brief is DENIED. Our 

records show this case is at issue and will be set for submission in due course.

/s/ CRAIG STODDART 

JUSTICE
No. 09-9540.

#### Andrew E. Warrington, Petitioner v. Perry Phelps, Warden, et al.

559 U.S. 1079, 130 S. Ct. 2118,

176 L. Ed. 2d 743,

2010 U.S. LEXIS 3388.

April 19, 2010.

Petition for writ of cer-tiorari to the United States Court of Appeals for the Third Circuit denied.
No. 09-8303.

#### Carlos L. Woodson, aka Carlo L. Woodson, Petitioner v. Katherine Rundle-Fernandez, State Attorney.

559 U.S. 1102, 130 S. Ct. 2399,

176 L. Ed. 2d 787,

2010 U.S. LEXIS 3495.

April 26, 2010.

Petition for rehearing denied.

Former decision, 559 U.S. 980, 130 S. Ct. 1705, 176 L. Ed. 2d 194, 2010 U.S. LEXIS 2144.
A
C
I
   ARMANDO C. IBARRA
            Certified Public
            Accountants
            A Professional Corporation


Armando C. Ibarra, C.P.A.
Members of the California Society of Certified Public Accountants
Armando Ibarra, Jr., C.P.A., JD
Members of the American Institute of Certified Public Accountants

Members of the Better Business Bureau since 1997




March 29, 2004


To Whom It May Concern:

The firm of Armando C. Ibarra, Certified Public Accountants, APC consents to
the inclusion of our report of March 25, 2004, on the audited financial
statements of Alpha Nutraceuticals, Inc. (formerly, Sierra-Rockies, Corp.),
as of December 31, 2003, in any filings that are necessary now or in the
near future with the U.S. Securities and Exchange Commission.



Very truly your


____________________________
ARMANDO C. IBARRA, C.P.A.


371 E. Street, Chula Vista, CA 91910
Tel: (619) 422-1348  Fax: (619) 422-1465
No. 09-1171.

#### Leslie Smith, Petitioner v. Psychiatric Solutions, Inc., et al.

560 U.S. 906, 130 S. Ct. 3293,

176 L. Ed. 2d 1186,

2010 U.S. LEXIS 3962.

May 17, 2010.

Petition for writ of cer-tiorari to the United States Court of Appeals for the Eleventh Circuit denied.

Same case below, 358 Fed. Appx. 76.
No. 09-1003.

#### Sergey Fisenko, Petitioner v. Eric H. Holder, Jr., Attorney General.

559 U.S. 1069, 130 S. Ct. 2111,

176 L. Ed. 2d 725,

2010 U.S. LEXIS 3340.

April 19, 2010.

Petition for writ of cer-tiorari to the United States Court of Appeals for the Sixth Circuit denied.

Same case below, 336 Fed. Appx. 504.
[Federal Register Volume 74, Number 9 (Wednesday, January 14, 2009)]
[Notices]
[Page 2083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-513]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Cancer Institute Clinical Trials Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Clinical Trials 
Advisory Committee.
    Date: March 4, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: Update on the progress of the implementation of the 
Clinical Trials Working Group and the Translational Research Working 
Group reports.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, 6th Floor, C-Wing, Conf. Room 10, Bethesda, MD 20892.
    Contact Person: Sheila A. Prindiville, MD, Director, 
Coordinating Center for Clinical Trials, Office of the Director, 
National Cancer Institute, National Institutes of Health, 6120 
Executive Blvd., Suite 507, Bethesda, MD 20892, 301-451-5048, 
<a href="/cdn-cgi/l/email-protection#ccbcbea5a2a8a5babf8ca1ada5a0e2a2a5a4e2aba3ba"><span class="__cf_email__" data-cfemail="2757554e49434e5154674a464e4b09494e4f09404851">[email protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 7, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-513 Filed 1-13-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
I 

109TH CONGRESS 

2D SESSION H. R. 4887 

To amend the Internal Revenue Code of 1986 to exclude from gross income 

amounts awarded to qui tam plaintiffs. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 7, 2006 

Ms. BERKLEY introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to exclude 

from gross income amounts awarded to qui tam plaintiffs. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EXCLUSION OF AMOUNTS AWARDED TO QUI 

4 TAM PLAINTIFFS. 

5 (a) IN GENERAL.—Part III of subchapter B of chap6 ter 1 of the Internal Revenue Code of 1986 (relating to 

7 items specifically excluded from gross income) is amended 

8 by inserting after section 139A the following new section: 


sroberts on PROD1PC70 with BILLS
2 

•HR 4887 IH 

1 ‘‘SEC. 139B. AWARD TO QUI TAM PLAINTIFF. 

2 ‘‘In the case of an individual, gross income does not 

3 include amounts awarded to such individual as a result 

4 of a qui tam action.’’. 

5 (b) CLERICAL AMENDMENT.—The table of sections 

6 for such part is amended by inserting after the item relat7 ing to section 139A the following new item: 

‘‘Sec. 139B. Award to qui tam plaintiff.’’. 

8 (c) EXTENSION OF PERIOD TO FILE AMENDED RE9 TURN.—Notwithstanding any other provision of law, an 

10 amended return made during the 3-year period beginning 

11 on the date of the enactment of this Act that includes the 

12 exclusion from gross income under section 139B of such 

13 Code in accordance with the amendment made by sub14 section (a) shall be treated as timely made for purposes 

15 of such Code. 

16 (d) EFFECTIVE DATE.—The amendments made by 

17 this section shall apply to amounts awarded to qui tam 

18 plaintiffs on or after January 1, 2002. 

Æ 


sroberts on PROD1PC70 with BILLS
Imperial County Air Pollution Control District Rule 804

804-1

RULE 804 OPEN AREAS

(Adopted 11/08/2005; Revised 10/16/2012)

A. Purpose

The purpose of this regulation is to reduce the amount of fine Particulate Matter 

(PM-10) entrained in the ambient air as a result of emissions generated from 

Open Areas by requiring actions to prevent, reduce, or mitigate PM-10 

emissions.

B. Applicability

This rule shall apply to any open area having 0.5 acres or more within urban 

areas, or 3.0 acres or more within rural areas; and contains at least 1000 square 

feet of disturbed surface area.

C. Definitions

The definition of terms found in Rule 800 (General Requirements for Control of 

Fine Particulate Matter (PM-10) shall apply to this rule.

D. Exemptions

In addition to the exemptions listed in Rule 800, Section E, the following 

exemptions are established for this rule:

D.1 Agricultural Operation Sites subject to Rule 806, Conservation 

Management Practices.

D.2 Recreational OHV Use Areas on public lands subject to Rule 800, General

Requirements for Control of Fine Particulate Matter (PM-10).

E. Requirements

E.1 Open Areas: all Persons who own or otherwise have jurisdiction over an 

Open Area shall comply with one or more of the requirements of Section 

F.1 to comply with the conditions of a Stabilized Surface at all times and 

limit VDE to 20% opacity.

E.2 Vehicle use in Open Areas: within 30 days following initial discovery of 

evidence of trespass, a Person who owns or otherwise has jurisdiction 

over an Open Area shall prevent unauthorized vehicle access by posting 

"No Trespassing" signs or installing physical barriers such as fences, 

gates, posts, and/or appropriate barriers to effectively prevent access to 

the area. 
Imperial County Air Pollution Control District Rule 804

804-2

F. Best Available Control Measures for Fugitive Dust (PM-10)

F.1 OPEN AREAS

F.1.a Apply and maintain water or dust suppressant(s) to all unvegetated 

areas.

F.1.b Establish vegetation on all previously disturbed areas.

F.1.c Pave, apply and maintain Gravel, or apply and maintain Chemical 

Stabilizers/Suppressants

G. Record of Control Implementation

Any Person subject to the requirements of this rule shall compile and retain 

records that provide evidence of control measure application (i.e., receipts and/or 

purchase records). Such Person shall describe, in the records, the type of 

treatment or control measure, extent of coverage, and date applied. For control 

measures which require multiple daily applications, recording the frequency of 

application will fulfill the recordkeeping requirements of this rule (i.e., water being 

applied three times a day and the date) Records shall be maintained and be 

readily accessible for two years after the date of each entry and shall be provided 

to the APCD upon request.

H. Violations

Failure to comply with any provisions of this rule shall constitute a violation of 

Regulation VIII.
Comment Info: =================

General Comment:FAA-2014-0423 (2013-NM-233-AD)
<PAGE>
 
                                                                    Exhibit 23.1



                        CONSENT OF INDEPENDENT AUDITORS


We consent to the incorporation by reference in the Registration Statement (Form
S-4 No. 333-45601) of Premier Bancshares, Inc. and in the related Prospectus and
in the Registration Statement (Form S-8 No. 333-29941) pertaining to the Premier
Bancshares, Inc. Directors' Stock Option Plan and the Premier Bancshares, Inc.
1997 Stock Option Plan of our report dated February 5, 1998, with respect to the
consolidated financial statements of Premier Bancshares, Inc. included in this
Annual Report (Form 10-K) for the year ended December 31, 1997.



                                       /s/ Ernst & Young LLP

March 12, 1998
Atlanta, Georgia
No. 09-9638.

#### Charles Bruce Thomas, Petitioner v. United States.

559 U.S. 1064, 130 S. Ct. 2127,

176 L. Ed. 2d 719,

2010 U.S. LEXIS 3198.

April 19, 2010.

Motion of petitioner for leave to proceed in forma pauperis denied, and petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit dismissed. See Rule 39.8. As petitioner has repeatedly abused this Court’s process, the Clerk is directed not to accept any further petitions in noncriminal matters from petitioner unless the docketing fee required by Rule 38(a) is paid and petition submitted in compliance with Rule 33.1. See Martin v. District of Columbia Court of Appeals, 506 U.S. 1, 113 S. Ct. 397, 121 L. Ed. 2d 305 (1992) (per curiam). Justice Stevens dissents. See id., at 4, 113 S. Ct. 397, 121 L. Ed. 2d 305, and cases cited therein.
UNCLASSIFIED

UNCLASSIFIED

Office of the Inspector General of the Intelligence Community 

Announces FY 2024 Independent Evaluation of the Office of the 

Director of National Intelligence’s Information Security Program 

and Practices Required by the Federal Information Security 

Modernization Act of 2014

(February 2024) The Office of the Inspector General of the Intelligence Community (IC IG) 

recently announced that it will conduct a fiscal year (FY) 2024 independent evaluation of the 

Office of the Director of National Intelligence (ODNI) information security program and practices. 

Under 44 U.S.C. §§ 3551-3558 (commonly known as the Federal Information Security 

Modernization Act of 2014 or FISMA), each agency inspector general (IG), or an independent 

external auditor, must conduct an annual independent evaluation to determine the effectiveness of 

the information security program and practices of its respective agency.

The objective of the evaluation is to assess the effectiveness and maturity of ODNI’s information 

security and practices. The evaluation will use the FY 2024 IG FISMA reporting metrics 

developed by the Office of Management and Budget, Department of Homeland Security, and the 

Council of the Inspectors General on Integrity and Efficiency. The IC IG contracted with an 

external firm to conduct the FY 2024 evaluation.

For more information about the IC IG, please contact ICIG_PAO@odni.gov or visit the IC IG’s website: 

https://www.dni.gov/icig 

For career opportunities with the IC IG, please visit: 

https://www.dni.gov/careers

To report allegations of waste, fraud, or abuse, please contact the IC IG Hotline: 

IC IG Hotline 855-731-3260 

ICIGHOTLINE@odni.gov
Exhibit
23.1





MOORE & ASSOCIATES,
CHARTERED
 ACCOUNTANTS AND
ADVISORS
 PCAOB
REGISTERED
 
 
 
 
 
 CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
 
 
 
 We
consent to the use, in the  statement on Form 10-KSB/A of Studio
One Media, Inc., of our report dated September 27,2007 on our
audit of the financial statements of Studio One Media, Inc., as of June 30, 2007
and June 30, 2006, and the related statements of operations,
stockholders’ equity and cash flows for the years then ended,  and
from inception on  July 1, 2002 through June 30, 2007, and the
reference to us under the caption "Experts."
 
 
 
 
 
 
 
 
 /s/ Moore & Associates, Chartered
 Moore
& Associates Chartered
 Las
Vegas, Nevada
 May
22, 2008
 
 
 
 
  
 
 
 
 
 
 
 
 
 2675 S. Jones Blvd. Suite
109, Las Vegas, NV 89146 (702)253-7511 Fax
(702)253-7501
Exhibit 31.1

Rule 13a-14(a)/15d-14(a) Certifications

I, Reed Fisher, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Cirracor, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the small business
issuer as of, and for, the periods presented in this report;

4. The small business issuer's other certifying officer(s) and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and
have:

(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the small business issuer, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the small business issuer's disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation and

(c) Disclosed in this report any change in the small business issuer's internal
control over financial reporting that occurred during the small business
issuer's most recent fiscal quarter (the small business issuer's fourth fiscal
quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the small business issuer's internal
control over financial reporting; and

5. The small business issuer's other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial reporting
, to the small business issuer's auditors and the audit committee of the small
business issuer's board of directors (or persons performing the equivalent
functions):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the small business issuer's ability to record,
process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's internal
control over financial reporting.

Date: May 19, 2005

/s/ Reed Fisher
----------------------
Reed Fisher
Chief Executive Officer and Chief Financial Officer